In the future, we will extend the assessment of patients at a 1-year follow-up to investigate whether the predictive value of irisin and NT-proBNP maintains their significance for different phenotypes of HF in T2DM patients. This evidence concerns the gene NPPB and type 2 diabetes mellitus.